Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Question for Eoganacht

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon May 12, 2023 4:02pm

147 Views

Post# 35446202

RE:RE:RE:RE:Question for Eoganacht

As far as I can tell, the question is related to the quote. 51% of enrolled patients. It says enrolled, not responders. 51% of enrollees would be astounding, right? Or did they really mean 51% of responders? Big difference. If we take the quote at face value then it's phenomenal, no? That's what NotPoop is asking, I believe.

"Overall, 51% of enrolled patients using Adstiladrin therapy achieved a complete response"

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?